Crinetics Pharmaceuticals CRNX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's accounts payable?
- Crinetics Pharmaceuticals (CRNX) reported accounts payable of $12.88M in Q1 2026.
- How has Crinetics Pharmaceuticals's accounts payable changed year-over-year?
- Crinetics Pharmaceuticals's accounts payable decreased by 59.3% year-over-year, from $31.62M to $12.88M.
- What is the long-term trend for Crinetics Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's accounts payable has grown at a 32.3% compound annual growth rate (CAGR), from $5.59M to $22.61M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.